Sep 22, 2026 08:03AM
Sep 22, 2026 08:00AM
Aug 21, 2026 07:04AM
May 20, 2026 06:49AM
Mar 23, 2026 06:48AM
Mar 18, 2026 05:31PM
Nov 14, 2025 07:00AM Marker Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Updates
Oct 6, 2025 07:45AM
Oct 6, 2025 07:30AM
May 19, 2025 08:00AM
Dec 17, 2024 07:01AM
Dec 17, 2024 07:00AM
Dec 17, 2024 07:00AM
Aug 14, 2024 04:30PM Marker Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Updates
May 15, 2024 04:15PM
Apr 30, 2024 06:46AM
Mar 25, 2024 05:45PM
Jan 8, 2024 08:25AM
Jan 8, 2024 08:24AM
Dec 21, 2023 11:00AM
Dec 11, 2023 07:05AM Marker Therapeutics (MRKR) Announces Sustained Complete Response in First Lymphoma Patient Treated with MT-601 following CAR T Relapse
Dec 11, 2023 07:00AM
Nov 9, 2023 05:00PM
Aug 14, 2023 04:30PM
Aug 7, 2023 07:13AM
Aug 7, 2023 07:00AM
Jul 10, 2023 07:02AM
Jul 10, 2023 07:00AM European Medicines Agency Grants Orphan Drug Designation for MT-401 developed by Marker Therapeutics for the Treatment of AML Patients
Jun 26, 2023 07:10AM
Jun 26, 2023 07:00AM
May 31, 2023 06:34AM
May 31, 2023 06:30AM
May 1, 2023 07:31AM
May 1, 2023 07:30AM
Mar 22, 2023 08:10AM Marker Therapeutics Reports Fiscal Year 2022 Corporate and Financial Results
Nov 22, 2022 07:04AM
Nov 22, 2022 07:00AM
Nov 10, 2022 04:05PM
Sep 13, 2022 07:02AM
Sep 13, 2022 07:00AM
Aug 11, 2022 04:22PM
Aug 4, 2022 04:39PM Marker Therapeutics (MRKR) Announces FDA Clearance of IND for MT-601
Aug 4, 2022 04:37PM
Jun 23, 2022 09:00AM
Apr 26, 2022 07:00AM
Mar 18, 2022 05:57AM
Mar 17, 2022 05:45PM
Feb 16, 2022 04:31PM
Feb 16, 2022 04:30PM Marker Therapeutics Announces Clinical Program Updates and Pipeline Expansion
Jan 19, 2022 04:50PM

334,273 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All